The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 8,501–8,600 of 31,469
Glucose homeostasis predicts weight gain: prospective and clinical evidence
Boulé, N. G., Chaput, J., Doucet, É., Richard, D., Després, J., Bouchard, C., & Tremblay, A. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.768 · Cited by 43
Grunnet, L. G., Vielwerth, S., Vaag, A. A., & Poulsen, P. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01793.x · Cited by 43
Increase in muscle nerve sympathetic activity after glucose intake is blunted in the elderly
Fagius, J., Ellerfelt, K., Lithell, H., & Berne, C. (1996) · Clinical Autonomic Research · doi:10.1007/bf02291134 · Cited by 42
Insulin and its role in chronic kidney disease
MAK, R. H. K. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0611-2 · Cited by 42
Is reduced baroreflex gain a component of the metabolic syndrome? Insights from the LINOSA study
Lucini, D., Cusumano, G., Bellia, A., Kozakova, M., Fede, G. D., Lauro, R., & Pagani, M. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000202817.02836.9c · Cited by 43
Fougner, K. J., Vanky, E., & Carlsen, S. M. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802254620 · Cited by 43
the Hertfordshire Cohort Study Group, Schlotz, W., Ambery, P., Syddall, H. E., Crozier, S., Sayer, A. A., Cooper, C. C., & Phillips, D. I. W. (2006) · Quality of Life Research · doi:10.1007/s11136-006-9129-5 · Cited by 43
Andersen, G., Harnack, K., Erbersdobler, H. F., & Somoza, V. (2008) · Annals of Nutrition and Metabolism · doi:10.1159/000140518 · Cited by 43
Fanelli, M., Filippi, E., Sentinelli, F., Romeo, S., Fallarino, M., Buzzetti, R., Leonetti, F., & Baroni, M. G. (2005) · Disease Markers · doi:10.1155/2005/576748 · Cited by 43
Caimari, A., Oliver, P., Rodenburg, W., Keijer, J., & Palou, A. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.10.001 · Cited by 43
Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome
Bıdecı, A., Çamurdan, M. O., Yeşilkaya, E., Demirel, F., & Cınaz, P. (2008) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2008.00819.x · Cited by 41
Waist Circumference Identifies Primary School Children with Metabolic Syndrome Abnormalities
Hirschler, V., Maccallini, G., Calcagno, M. D. L., Aranda, C., & Jadzinsky, M. N. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.0017 · Cited by 43
Tretjakovs, P., Jurka, A., Bormane, I., Miķelsone, I., Elksne, K., Krieviņa, G., Reihmane, D., Verbovenko, J., & Bahs, G. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.10.009 · Cited by 43
Kabat, G. C., Kim, M. Y., Strickler, H. D., Shikany, J. M., Lane, D. S., Luo, J., Ning, Y., Gunter, M. J., & Rohan, T. E. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.512 · Cited by 43
Sanghera, D. K., Been, L. F., Ortega, L., Wander, G. S., Mehra, N. K., Aston, C. E., Mulvihill, J. J., & Ralhan, S. K. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.7 · Cited by 42
Kim, Y. M., Cha, B. S., Kim, D. J., Choi, S. H., Kim, S. K., Ahn, C. W., Lim, S.-K., Kim, K. R., Huh, K. B., & Lee, H. C. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.05.001 · Cited by 43
Midaoui, A. E., & de Champlain, J. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160215.78973.ba · Cited by 43
Ybarra, J., Resmini, E., Planas, F., Navarro-López, F., Webb, S. M., Pou, J. M., Vives, A. S., & Ballesta‐López, C. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9924-5 · Cited by 44
MALIK, A., Cheah, P., Hilmi, I. N., et al. (2007) · Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2007.00286.x · Cited by 43
Bajnok, L., Seres, I., Varga, Z., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.022 · Cited by 43
Bower, J. F., Deshaies, Y., Pfeifer, M. A., Tanenberg, R. J., & Barakat, H. A. (2002) · Metabolism · doi:10.1053/meta.2002.29991 · Cited by 43
Bahçeci, M., Tuzcu, A., Bahçeci, S., & Tuzcu, Ş. A. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347025 · Cited by 43
Tanaka, M., Yoshida, T., Wu, B., Fukuo, K., & Kazumi, T. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11940 · Cited by 43
The association between leptin and left ventricular hypertrophy
Pladevall, M., Williams, K. L., Guyer, H., Sadurní, J. R., Falces, C., Ribes, A., Paré, C., Brotons, C., Gabriel, R., Serrano‐Ríos, M., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200308000-00009 · Cited by 42
Benhalima, K., Crombrugge, P. V., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Dufraimont, E., Block, C. E. M. D., Jacquemyn, Y., Mekahli, F., et al. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-226 · Cited by 44
Utzschneider, K. M., de Lagemaat, A. V., Faulenbach, M. V., Goedecke, J. H., Carr, D. B., Boyko, E. J., Fujimoto, W. Y., & Kahn, S. E. (2010) · Obesity · doi:10.1038/oby.2010.77 · Cited by 43
Barker, J. M., McFann, K., Harrison, L. C., Fourlanos, S., Krischer, J. P., Cuthbertson, D. D., Chase, H. P., & Eisenbarth, G. S. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.09.033 · Cited by 44
Association of Variation in the Interleukin-1 Gene Family with Diabetes and Glucose Homeostasis
Luotola, K., Pääkkönen, R., Alanne, M., Lanki, T., Moilanen, L., Surakka, I. L., Pietilä, A., Kähönen, M. A. P., Nieminen, M. S., Kesäniemi, Y. A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0666 · Cited by 43
Sung, K., Reaven, G. M., & Kim, S. H. (2009) · Diabetes Care · doi:10.2337/dc09-1070 · Cited by 43
Dougherty, R. H., Rohrer, J. L., Hayden, D., Rubin, S. D., & Leder, B. Z. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02205.x · Cited by 43
Goldstein, I. B., Shapiro, D., & Weiss, R. E. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f15c27 · Cited by 44
Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.
Schneider, J. G., von Eynatten, M., Parhofer, K., Volkmer, J., Schiekofer, S., Hamann, A., Nawroth, P., & Dugi, K. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.003 · Cited by 48
Pereira, M. A., & Fulgoni, V. L. I. (2010) · Journal of the American College of Nutrition · doi:10.1080/07315724.2010.10719901 · Cited by 43
Dietary trans-fat combined with monosodium glutamate induces dyslipidemia and impairs spatial memory
Collison, K. S., Makhoul, N. J., Inglis, A. L., Al‐Johi, M. A., Zaidi, M. Z., Maqbool, Z. M., Saleh, S. M., Bakheet, R., Mondreal, R., Al‐Rabiah, R. K., et al. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.11.010 · Cited by 42
Guinan, E. M., Connolly, E. M., Healy, L., Carroll, P. A., Kennedy, M. J., & Hussey, J. M. (2013) · Cancer Nursing · doi:10.1097/ncc.0b013e3182a40e6d · Cited by 43
Stolerman, E. S., Manning, A. K., McAteer, J. B., Dupuis, J., Fox, C. S., Cupples, L. A., Meigs, J. B., & Florez, J. C. (2008) · Diabetes · doi:10.2337/db08-0266 · Cited by 43
Metabolic syndrome is associated with erosive esophagitis
Park, J. H., Park, D. I., Kim, H. J., et al. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5442 · Cited by 43
Tessari, P., Kiwanuka, E., Millioni, R., Vettore, M., Puricelli, L., Zanetti, M., Gucciardi, A., Tosolini, M., Cogo, P. E., Carnielli, V. P., et al. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-0226 · Cited by 43
Palou, M., Sánchez, J., García‐Carrizo, F., Palou, A., & Picó, C. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500292 · Cited by 41
Guallar‐Castillón, P., Oliveira, A., Lopes, C. M. M., López‐García, E., & Rodríguez‐Artalejo, F. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.035 · Cited by 45
Giusti, V., Suter, M., Verdumo, C., Gaillard, R. C., Burckhardt, P., & Pralong, F. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031507 · Cited by 43
Wong, S., Huda, M. S. B., English, P., Bargiotta, A., Wilding, J. P. H., Johnson, A., Corrall, R. J. M., & Pinkney, J. H. (2005) · Diabetologia · doi:10.1007/s00125-005-0038-x · Cited by 42
Chekir, C., Nakatsuka, M., Kamada, Y., Noguchi, S., Sasaki, A., & Hiramatsu, Y. (2005) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2005.00678.x · Cited by 43
Weight History, Glucose Intolerance, and Insulin Levels in Middle-aged Swedish Men
Carlsson, S., Persson, P.-G., Alvarsson, M., Efendic, S., Norman, A., Svanström, L., Östenson, C., & Grill, V. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009679 · Cited by 41
Change in cutaneous perfusion following 10 weeks of aerobic training in Type 2 diabetes
Colberg, S. R., Parson, H. K., Nunnold, T., Holton, D. R., Swain, D. P., & Vinik, A. I. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.02.006 · Cited by 43
Orosomucoid Serum Concentrations and Fat Depot-Specific mRNA and Protein Expression in Humans
Alfadda, A. A., Fatma, S., Chishti, M. A., Al-Naami, M. Y., Elawad, R., Mendoza, C. D. O., Jo, H., & Lee, Y. S. (2011) · Molecules and Cells · doi:10.1007/s10059-012-2181-9 · Cited by 43
Sex Hormone–Binding Globulin and Testosterone in Individuals With Childhood Diabetes
Danielson, K. K., Drum, M. L., & Lipton, R. B. (2008) · Diabetes Care · doi:10.2337/dc07-2169 · Cited by 43
Kim, O. Y., Lim, H. H., Yang, L. I., Chae, J. S., & Lee, J. H. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-24 · Cited by 43
Danielson, K. K., Drum, M. L., Estrada, C. L., & Lipton, R. B. (2009) · Diabetes Care · doi:10.2337/dc09-1220 · Cited by 43
Kawagishi, T., Matsuyoshi, M., Emoto, M., Taniwaki, H., Kanda, H., Okuno, Y., Inaba, M., Ishimura, E., Nishizawà, Y., & Morii, H. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.10.2509 · Cited by 43
Pulmonary function and sleep-related breathing disorders in severely obese children
Dubern, B., Tounian, P., Medjadhi, N., Maingot, L., Girardet, J.-P., & Boulé, M. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2005.12.001 · Cited by 42
da Silva, T. F., Levy‐Neto, M., Bonfá, E., & Pereira, R. M. R. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.130162 · Cited by 43
New-onset Diabetes Patients Need Pancreatic Cancer Screening?
Lee, J. H., Kim, S., Park, H. Y., Lee, K. H., Lee, K. T., Lee, J. K., Bae, J. C., & Kim, K. W. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318238348c · Cited by 43
Michaud, A., Tordjman, J., Pelletier, M., Liu, Y., Laforest, S., Noël, S., Naour, G. L., Bouchard, C., Clément, K., & Tchernof, A. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.173 · Cited by 45
(2005) · Diabetes Care · doi:10.2337/diacare.28.10.2472 · Cited by 43
Cederholm, A., Svenungsson, E., Stengel, D., Fei, G., Pockley, A. G., Ninio, E., & Frostegård, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20432 · Cited by 43
Weight cycling and cardiovascular risk factors in obesity
Graci, S., Izzo, G., Savino, S., Cattani, L., Lezzi, G., Berselli, M. E., Balzola, F., Liuzzi, A., & Petroni, M. L. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802537 · Cited by 43
Galtier, F., Farret, A., Verdier, R., Barbotte, É., Nocca, D., Fabre, J.-M., Bringer, J., & Renard, É. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803247 · Cited by 43
Fagot‐Campagna, A., Narayan, K. M. V., Hanson, R. L., Imperatore, G., Howard, B. V., Nelson, R. G., Pettitt, D. J., & Knowler, W. C. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)05978-3 · Cited by 42
Colao, A., Somma, C. D., Rota, F., Maio, S. D., Salerno, M., Klain, A., Spiezia, S., & Lombardi, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1844 · Cited by 43
Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion
Adami, G. F., Cordera, R., Camerini, G. B., Marinari, G. M., & Scopinaro, N. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00189-6 · Cited by 43
Frénais, R., Nazih, H., Ouguerram, K., Maugeais, C., Zaïr, Y., Bard, J., Charbonnel, B. H., Magot, T., & Krempf, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7480 · Cited by 43
Ambye, L., Rasmussen, S. L., Fenger, M., Jørgensen, T., Borch‐Johnsen, K., Madsbad, S., & Urhammer, S. A. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.06.013 · Cited by 44
Halle, M., Berg, A., Keul, J., & Baumstark, M. W. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.144 · Cited by 43
An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study
Manolakopoulos, S., Bethanis, S., Liapi, C. A., et al. (2007) · BMC Gastroenterology · doi:10.1186/1471-230x-7-17 · Cited by 43
Calvo, R. M., Tellerı́a, D., Sancho, J., Millán, J. L. S., & Escobar-Morreale, H. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03238-1 · Cited by 43
Pannacciulli, N., Cantatore, F. P., Minenna, A., et al. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00914.x · Cited by 43
Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG
Jonkers, I. J. A. M., Smelt, A. H. M., Hattori, H., Scheek, L. M., van Gent, T., de Man, F. H. A. F., van der Laarse, A., & van Tol, A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300008-jlr200 · Cited by 43
A paired-sibling analysis of the XbaI polymorphism in the muscle glycogen synthase gene
Orho‐Melander, M., Almgren, P.-E., Kanninen, T., Forsblom, C. M., & Groop, L. (1999) · Diabetologia · doi:10.1007/s001250051282 · Cited by 42
Li, S., Chen, W., Srinivasan, S. R., Boerwinkle, E., & Berenson, G. S. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1265 · Cited by 43
Kerstens, M. N., Riemens, S. C., Sluiter, W. J., Pratt, J. J., Wolthers, B. G., & Dullaart, R. P. F. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00975.x · Cited by 43
Gray, R. P. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06070-4 · Cited by 41
Katsuki, A., Sumida, Y., Murata, K., Furuta, M., Araki-Sasaki, R., Tsuchihashi, K., Hori, Y., Yano, Y., Gabazza, E. C., & Adachi, Y. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00072.x · Cited by 43
Fasting hyperinsulinemia and increased waist-to-hip ratios in non-wasting individuals with AIDS
Shikuma, C. M., Waslien, C., McKeague, J., et al. (1999) · AIDS · doi:10.1097/00002030-199907300-00013 · Cited by 43
Shoemaker, M. E., Pereira, S. L., Mustad, V. A., Gillen, Z. M., McKay, B. D., Lopez‐Pedrosa, J. M., Rueda, R., & Cramer, J. T. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12932 · Cited by 43
“Homeostatic model assessment of insulin resistance (HOMA-IR) was calculated using fasting glucose and insulin concentrations with the following formula derived from Matthews et al.(22): 1228 M.”
MethodInfluentialZinc supplementation reduces diet-induced obesity and improves insulin sensitivity in rats
Thoen, R. U., Barther, N. N., Schemitt, E., Bona, S., Fernandes, S., Coral, G., Marroni, N. P., Tovo, C., Guedes, R. P., & Porawski, M. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0519 · Cited by 43
“- Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index The HOMA-IR index was calculated using the following equation: [fasting insulin levels x fasting glucose levels] / 22.5 (Matthews et al. 1985).”
MethodInfluentialToloza, F. J. K., Mantilla-Rivas, J. O., Pérez-Matos, M. C., Ricardo-Silgado, M. L., Morales-Alvarez, M. C., Pinzón-Cortés, J. A., Pérez-Mayorga, M., Arévalo-Garcia, M. L., Tolosa-González, G., & Mendivil, C. O. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00005 · Cited by 42
Shimazaki, T., Kadowaki, T., Ohyama, Y., Ohe, K., & Kubota, K. (2007) · Translational research · doi:10.1016/j.trsl.2006.09.008 · Cited by 42
Keihanian, A., Arazi, H., & Kargarfard, M. (2019) · Physiology International · doi:10.1556/2060.106.2019.01 · Cited by 42
“Insulin resistance index (HOMA-IR) was calculated according to the formula (31): HOMA-IR = (fasting glucose (mmol/L) × fasting insulin (mU/L)/22.”
MethodBeck Jørgensen, S., O’Neill, H. M., Hewitt, K., Kemp, B. E., & Steinberg, G. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1483-8 · Cited by 42
Plasma Cytokines, Metabolic Syndrome, and Atherosclerosis in Humans
Reilly, M. P., Rohatgi, A., McMahon, K., Wolfe, M. L., Pinto, S. C., Rhodes, T., Girman, C., & Rader, D. J. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.06013 · Cited by 42
Glucose Metabolism in Pregnancy at High Altitude
Krampl, E., Kametas, N. A., Nowotny, P., Roden, M., & Nicolaides, K. H. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.817 · Cited by 41
Individual variations in glycemic responses to carbohydrates and underlying metabolic physiology
Wu, Y., Ehlert, B., Metwally, A. A., Perelman, D., Park, H., Brooks, A. W., Abbasi, F., Michael, B., Celli, A., Bejikian, C., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03719-2 · Cited by 48
Metabolic syndrome and its components among obese (BMI ≥95th) Mexican adolescents
Evia-Viscarra, M. L., Rodea-Montero, E. R., Apolinar‐Jiménez, E., & Quintana-Vargas, S. (2013) · Endocrine Connections · doi:10.1530/ec-13-0057 · Cited by 42
The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients
Luukkonen, P. K., Qadri, S. U., Lehtimäki, T. E., Juuti, A., Sammalkorpi, H. E., Penttilä, A. K., Hakkarainen, A., Orho‐Melander, M., Arola, J. T., & Yki‐Järvinen, H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa729 · Cited by 42
Aliahmadi, M., Amiri, F., Bahrami, L. S., Hosseini, A. F., Abiri, B., & Vafa, M. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00798-z · Cited by 48
Al-Muzafar, H. M., Alshehri, F. S., & Amin, K. A. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2020e10782 · Cited by 49
Tura, A., Grespan, E., Göbl, C. S., Koivula, R. W., Franks, P. W., Pearson, E. R., Walker, M., Forgie, I. M., Giordano, G. N., Pavo, I. J., et al. (2021) · Diabetes · doi:10.2337/db21-0227 · Cited by 45
Xu, T., Yu, Z. H., Liu, Y., Lu, M., Gong, M., Li, Q., Xia, Y., & Xu, B. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02609-1 · Cited by 45
Pedersen, J. S., Rygg, M. O., Chrøis, K. M., Sustarsic, E. G., Gerhart‐Hines, Z., Albrechtsen, N. J. W., Serizawa, R., Kristiansen, V. B., Basse, A. L., Boilesen, A. E. B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30629-5 · Cited by 42
Kim, E. R., Kim, S. R., Cho, W., Lee, S., Kim, S. H., Kim, J. H., Choi, E., Kim, J., Yu, J., Lee, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843520 · Cited by 44
Ciaraldi, T. P., BOEDER, S. C., Mudaliar, S. R. D., Giovannetti, E. R., Henry, R. R., & Pettus, J. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15070 · Cited by 45
The relationship between triglyceride-glucose index and albuminuria in United States adults
Wang, Z., Qian, H., Zhong, S., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1215055 · Cited by 42
Ghoreishi, P. S., Shams, M., Nimrouzi, M., Zarshenas, M. M., Lankarani, K. B., Fallahzadeh, E., Talebzadeh, M., & Hashempur, M. H. (2023) · Journal of Dietary Supplements · doi:10.1080/19390211.2023.2263788 · Cited by 49
Healy, L., Howard, J. M., Ryan, A. M., et al. (2011) · Colorectal Disease · doi:10.1111/j.1463-1318.2011.02562.x · Cited by 42
CTRP1 protects against diet-induced hyperglycemia by enhancing glycolysis and fatty acid oxidation
Han, S., Park, J. S., Lee, S., Jeong, A. L., Oh, K. S., Ka, H. I., Choi, H., Son, W., Lee, W., Oh, S. J., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.018 · Cited by 41
Matikainen, N., Adiels, M., Söderlund, S., Stennabb, S., Ahola, T. M., Hakkarainen, A., Borén, J., & Taskinen, M. (2014) · Obesity · doi:10.1002/oby.20781 · Cited by 43
Derosa, G., Maffioli, P., Ferrari, I., D’Angelo, A., Fogari, E., Palumbo, I., Randazzo, S., & Cicero, A. F. G. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00888.x · Cited by 42
Berezina, A. V., Belyaeva, О. D., Беркович, О. А., Баранова, Е. И., Каронова, Т. Л., Bazhenova, E., Бровин, Д. Л., Grineva, E. N., & Shlyakhto, E. (2015) · BioMed Research International · doi:10.1155/2015/548734 · Cited by 40
Arshi, B., Tohidi, M., Derakhshan, A., Asgari, S., Azizi, F., & Hadaegh, F. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.70 · Cited by 43
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
